Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sugati Ventures is an early-stage health tech fund based in the United States, focusing on Seed and Series A investments. The firm collaborates with entrepreneurs to create impact in healthcare, leveraging a global network to support its portfolio. Specific fund size and assets under management are not disclosed.
The firm invests in healthcare startups at the proof of concept or early growth stages, targeting companies with strong founding teams and recognized market needs. Sugati Ventures emphasizes global applicability and seeks clear pathways to acquisition or reimbursement for its portfolio companies.
Notable portfolio companies include Neurava, which detects seizure frequency and severity; Tempo, utilizing MAP technology for functional tissue and organ development; Perceive Now, an AI-based operating system for integrated platform intelligence; Oatmeal, the first reimbursable AI platform for lung cancer screening; Truss Health, offering AI-driven remote patient safety monitoring; and Solenic Medical Inc., innovating non-invasive solutions for infected metallic implants.
Submit your pitch through their form at sugativentures.com or email rachna@sugativentures.com with your deck.
Yes, Sugati Ventures often leads investment rounds in the healthcare startups they back, particularly in the Seed and Series A stages.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth and meet their investment criteria.
The exact size of Sugati Ventures' current fund is not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.